The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships, Workshop Summary
public disclosure or (2) with all parties involved with intent to publicly disclose information related to the biomarker, target, or specific imaging study in a timely manner. The latter scenario may be covered under RCH as a project with the Biomarker Consortium. In all cases, the rules of engagement for the scope and timing of information shared throughout the process will be established before each project begins by the RCH facilitator and the pharmaceutical companies/academic partner involved, according to Dr. Dean F. Wong, professor of radiology and psychiatry, vice chair radiology research and section director of high resolution brain imaging at the Johns Hopkins University.